Paper Details

  1. Home
  2. Paper Details

Ziprasidone for schizophrenia and severe mental illness.

Author: BagnallA, KleijnenJ, LeitnerM L, LewisR A

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This study discusses the use of atypical antipsychotic drugs in treating schizophrenia, highlighting the benefits of atypical drugs, such as ziprasidone, in terms of reduced side effects and potential for greater patient acceptance.
Paper Details　
Original Abstract of the Article :
Typical antipsychotic drugs are widely used as the first line treatment for people with schizophrenia. However, the atypical class of antipsychotic drugs are making important inroads into this approach. Atypical is a widely used term used to describe some antipsychotics which have a low propensity t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD001945

データ提供：米国国立医学図書館（NLM）

Ziprasidone: A Newer Atypical Antipsychotic for Schizophrenia

Schizophrenia, a complex mental illness, presents significant challenges in treatment. This study explores the use of ziprasidone, a newer atypical antipsychotic, for managing schizophrenia and other severe mental illnesses.

Ziprasidone's Potential in Treating Schizophrenia

The study suggests that ziprasidone, with its high serotonin/dopamine receptor affinity, may be a promising treatment option for schizophrenia. The research highlights the growing role of atypical antipsychotics in managing this complex condition. The study points to the potential benefits of ziprasidone, such as its reduced likelihood of causing movement disorders, sedation, and elevated prolactin levels.

Navigating Treatment Options for Schizophrenia

The use of atypical antipsychotics, like ziprasidone, represents a positive development in the treatment of schizophrenia. This research encourages further investigation into the efficacy and safety of this newer class of medications for patients living with schizophrenia. Understanding the unique characteristics of these medications will help clinicians choose the most appropriate treatment strategies for their patients.

Dr.Camel's Conclusion

This research delves into the promising potential of ziprasidone, a newer atypical antipsychotic, for managing schizophrenia. The study highlights the importance of exploring various treatment options for this complex mental illness. By understanding the distinct properties of atypical antipsychotics, clinicians can better tailor treatment plans to meet the individual needs of their patients.

Date :
  1. Date Completed 2000-07-06
  2. Date Revised 2020-05-11
Further Info :

Pubmed ID

10796670

DOI: Digital Object Identifier

10.1002/14651858.CD001945

Related Literature

Article Analysis
・Effective treatment of schizophrenia
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.